Literature DB >> 12055081

Single cysteine to tyrosine transition inactivates the growth inhibitory function of Piedmontese myostatin.

Carole Berry1, Mark Thomas, Brett Langley, Mridula Sharma, Ravi Kambadur.   

Abstract

Myostatin, a member of the transforming growth factor-beta superfamily, is a secreted growth factor that is proteolytically processed to give COOH-terminal mature myostatin and NH2-terminal latency-associated peptide in myoblasts. Piedmontese cattle are a heavy-muscled breed that express a mutated form of myostatin in which cysteine (313) is substituted with tyrosine. Here we have characterized the biology of this mutated Piedmontese myostatin. Northern and Western analyses indicate that there is increased expression of myostatin mRNA and precursor myostatin protein in the skeletal muscle of Piedmontese cattle. In contrast, a decrease in mature myostatin was observed in Piedmontese skeletal muscle. However, there is no detectable change in the circulatory levels of mature myostatin in Piedmontese cattle. Myoblast proliferation assay performed with normal and Piedmontese myostatin indicated that mature wild-type myostatin protein inhibited the proliferation of C2C12 myoblasts. Piedmontese myostatin, by contrast, failed to inhibit myoblast proliferation. In addition, when added in molar excess, Piedmontese myostatin acted as a potent "competitive inhibitor" molecule. These results indicate that, in Piedmontese myostatin, substitution of cysteine with tyrosine results in the distortion of the "cystine knot" structure and a loss of biological activity of the myostatin. This mutation also appears to affect either processing or stability of mature myostatin without altering the secretion of myostatin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055081     DOI: 10.1152/ajpcell.00458.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  20 in total

1.  Enhanced skeletal muscle growth in myostatin-deficient transgenic pigs had improved glucose uptake in stretozotocin-induced diabetes.

Authors:  Biao Li; Wentao Cui; Jinzeng Yang
Journal:  Transgenic Res       Date:  2020-02-20       Impact factor: 2.788

2.  Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.

Authors:  Carlene S Starck; Andrew J Sutherland-Smith
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 3.  Clinical, agricultural, and evolutionary biology of myostatin: a comparative review.

Authors:  Buel D Rodgers; Dilip K Garikipati
Journal:  Endocr Rev       Date:  2008-06-30       Impact factor: 19.871

4.  Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15.

Authors:  Qinglei Li; Saneal Rajanahally; Mark A Edson; Martin M Matzuk
Journal:  Mol Hum Reprod       Date:  2009-08-03       Impact factor: 4.025

5.  Production of transgenic calves expressing an shRNA targeting myostatin.

Authors:  K Tessanne; M C Golding; C R Long; M D Peoples; G Hannon; M E Westhusin
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

6.  The C313Y Piedmontese mutation decreases myostatin covalent dimerisation and stability.

Authors:  Carlene S Starck; Andrew J Sutherland-Smith
Journal:  BMC Res Notes       Date:  2011-10-24

7.  Inferring the transcriptional landscape of bovine skeletal muscle by integrating co-expression networks.

Authors:  Nicholas J Hudson; Antonio Reverter; YongHong Wang; Paul L Greenwood; Brian P Dalrymple
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

8.  Novel PRMT7 mutation in a rare case of dysmorphism and intellectual disability.

Authors:  Jessie Poquérusse; Whitney Whitford; Juliet Taylor; Salam Alburaiky; Russell G Snell; Klaus Lehnert; Jessie C Jacobsen
Journal:  J Hum Genet       Date:  2021-07-09       Impact factor: 3.172

9.  Beyond differential expression: the quest for causal mutations and effector molecules.

Authors:  Nicholas J Hudson; Brian P Dalrymple; Antonio Reverter
Journal:  BMC Genomics       Date:  2012-07-31       Impact factor: 3.969

10.  Functional effect of mir-27b on myostatin expression: a relationship in Piedmontese cattle with double-muscled phenotype.

Authors:  Silvia Miretti; Eugenio Martignani; Paolo Accornero; Mario Baratta
Journal:  BMC Genomics       Date:  2013-03-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.